In our prognostic model, overexpression of PZP, LCAT, GRAMD1C, and ANGPTL1 was associated with better prognosis in HCC patients, while overexpression of HMMR and LPL was associated with worse prognosis. Here, GRAMD1C is linked to hepatocellular carcinoma.